| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |